Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zim Laboratories has submitted copies of newspaper advertisements of its unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26), published on 8 August 2025 in Financial Express, Indian Express, and Loksatta. This is a routine compliance filing under SEBI Listing Regulations. The published consolidated results show total income from operations of Rs 7,175.61 lakhs in Q1 FY26, down from Rs 10,873.30 lakhs in Q1 FY25. Net profit after tax fell to Rs 76.14 lakhs from Rs 236.96 lakhs a year earlier, and basic EPS dropped to Rs 0.83 from Rs 1.04. The board had approved these results at its meeting on 7 August 2025, and they were already filed with the stock exchanges earlier under Regulation 33.
The filing itself is procedural, but the underlying numbers reveal a significant year-on-year decline in both revenue (around 34% lower) and profit (around 68% lower) for Q1 FY26, which is mildly negative for the stock in the short term.